George L. Bakris, MD, received his medical degree from the Chicago Medical School and completed his residency in Internal Medicine at the Mayo Graduate School of Medicine where he also did a research fellowship in Physiology and Biophysics. He then completed fellowships in Nephrology and Clinical Pharmacology at the University of Chicago. From 1988 to 1991 he served as Director of Renal Research at the Ochsner Clinic and was a faculty member of Tulane University School of Medicine. He was also Professor and Vice Chairman of Preventive Medicine and Director of the Rush University Hypertension Center in Chicago, Illinois from 1993 until 2006. Currently, he is Professor of Medicine and Director, ASH Comprehensive Hypertension Center in the Section of Endocrinology, Diabetes, and Metabolism at the University of Chicago Medicine.
Dr. Bakris has been extensively involved as either a principal investigator or on the steering committees of national and international trials involving diabetic kidney disease progression and resistant hypertension. He is the principal investigator of the FIDELIO trial evaluating a novel agent on progression of diabetic kidney disease. He is also on the steering committee of two other international trials involving agents that lower blood pressure or blood sugar and assessing effects on diabetic kidney disease progression. He recently completed studies on renal denervation for resistant hypertension and use of a recently FDA-approved agent, patiromer, for controlling serum potassium in high-risk people with advanced kidney disease.